References
- Czaja AJ. Serologic markers of hepatitis A and B in acute and chronic liver disease. Mayo Clin Proc 1979 Nov:54:721–32
- Centers for Disease Control. Inactivated hepatitis B virus vaccine. Morbid Mortal Weekly Rep 1982 Jun 25:31:317–28
- Chin J. The use of hepatitis B virus vaccine. (Editorial) N Engl J Med 1982 Sep 9:307:678–9
- Centers for Disease Control. Hepatitis B virus vaccine safety: report of an inter-agency group. Morbid Mortal Weekly Rep 1982 Sep 3:31:465–7
- Centers for Disease Control. Possible transfusion-associated acquired immune deficiency syndrome (AIDS)—California. Morbid Mortal Weekly Rep 1982 Dec 10:31:652–4
Bibliography
- Dienstag JL. Toward the control of hepatitis B. N Engl J Med 1980 Oct 9:303:874–6
- Hepatitis B vaccine. Med Lett Drugs Ther 1982 Aug 20:24:75–6
- Maynard JE. Prevention of hepatitis B through the use of vaccine. Ann Intern Med 1982: 97(3):442–4
- Mulley AG, Silverstein MD, Dienstag JL. Indications for use of hepatitis B vaccine based on cost effectiveness analysis. N Engl J Med 1982: 307(11):644–52
- Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980 Oct 9:303:833–45